Dermatitis, Eczematous Recruiting Phase 3 Trials for Dupilumab (DB12159)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03720470Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical TherapyTreatment